<DOC>
	<DOCNO>NCT02855411</DOCNO>
	<brief_summary>The purpose study determine whether PF-04958242 safe effective treatment cognitive dysfunction schizophrenia subject</brief_summary>
	<brief_title>A Study To Evaluate The Safety And Efficacy Of PF-04958242 In Subjects With Cognitive Impairment Associated With Schizophrenia ( CIAS )</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Cognition Disorders</mesh_term>
	<criteria>Otherwise healthy male and/or female subject age 18 50 year , inclusive , Diagnostic Statistical Manual Mental Disorders , Fifth Edition ( DSM5 ) diagnosis schizophrenia least 2 year duration confirm M.I.N.I 7.0 Psychotic Disorders Evidence stable schizophrenia symptomatology &gt; =3 month ( ie , hospitalization schizophrenia , increase level psychiatric care due worsen symptom schizophrenia ) . Subjects must ongoing maintenance atypical antipsychotic therapy ( except clozapine ) , stable treatment regimen &gt; =2 month prior Baseline/Day 1 , include concomitant psychotropic treatment . Subjects 2 background antipsychotic . Subject must identify informant Subject must reside stable live situation least 12 week prior Screening . Subjects current DSM5 diagnosis schizoaffective disorder judgment investigator . Subjects current DSM5 diagnosis major depressive episode , manic hypomanic episode , panic disorder , agoraphobia , social anxiety disorder , obsessivecompulsive disorder , posttraumatic stress disorder , generalize anxiety disorder M.I.N.I 7.0 Psychotic Disorders judgment investigator . Subjects lifetime DSM5 diagnosis antisocial personality disorder , anorexia nervosa , bulimia nervosa , bingeeating disorder M.I.N.I 7.0 Psychotic Disorders judgment investigator . Subjects meet DSM5 diagnosis moderate severe psychoactive substance use disorder ( exclude nicotine dependence ) within 12 month screen M.I.N.I 7.0 Psychotic Disorders interview determine investigator . Subjects significant extrapyramidal symptom stabilize anticholinergic .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>